Trial Profile
French Evaluation Group Avastin Versus Lucentis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Sep 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- Acronyms GEFAL
- 29 Sep 2015 New trial record